There are many different types of microbial contamination that can occur in pharmaceutical manufacturing. Some of the sources include: water, raw materials, excipients, in-process materials and samples, the manufacturing process, the product itself, and the general manufacturing environment. As such, there is no one size fits all investigation.
Microbiological testing covers a wide range of products, processes and environments, therefore representative samples from each of these categories forms the basis of what gets investigated. The role of QC Microbiology in the identification and investigation of various results from manufacturing areas and finished product testing is extremely important.
Why You Should Attend:
Medical device regulations in the US and the EU are foundational to the remainder of the regulations that are applied to medical devices throughout the world. An inspection by a representative of a regulatory body or a complaint from the market could uncover regulatory violations that may result in sanctions of various levels of seriousness. These sanctions could result in diminished reputation, device recalls, extended intrusive monitoring, and/or civil and criminal penalties.
It is important to understand how regulatory agencies in both the US and the EU are structured and function and the specific medical device regulations within each jurisdiction that apply to maintain sound medical device compliance.
Now, with the EU’s new Medical Device Regulation of over 400 pages soon to be law and the complexities of medical device regulations in the US, it is critical to effective regulatory compliance that all levels of management all along the supply chain, understand how the process works and have at least a basic understanding of the key regulations and their contents.
Areas Covered in the Session :
This course will describe the actions that should be taken when a sterility test failure occurs. What happens when a suspect microbial result is reported? What does it look like, and how should you react? This webinar will review when it is appropriate to investigate a result that may seem “out of the ordinary.”
By attending this interactive session, you will learn:
FDA Regulations and Guidance on Sterility Failure Investigations
Stages of Investigation: Lab Investigation vs. Manufacturing Investigation
Tools to use to help determine Root Cause
How to categorize sterility results
How to address impact to lots affected
Areas, parameters and variables to investigate as part of the investigation
Proper documentation of the Investigation
CAPA plans that address root cause
Who Should Attend:
Quality Assurance Departments
Quality Control Departments
Manufacturing Departments
Facilities & Engineering Departments
Chemistry & Microbiology Departments